Thomas D. Stern is a managing director and principal of Chieftain Capital Management, a New York City-based investment advisory firm.
He and his wife, Dr. Denise Stern, have dedicated a significant amount of time and resources to finding a cure for type 1 diabetes ever since their daughter, Samantha, was diagnosed with the disease at the age of 22 months.
The Sterns have co-chaired the DRI Foundation's New York Research Update for several years and are actively involved with the organization's fundraising efforts throughout the New York area. They have been generous contributors to the Diabetes Research Institute Foundation (DRIF) and in recognition of their support, the Diabetes Research Institute's Dr. Denise R. Stern and Thomas D. Stern Fast Track Center bears their name.
Additionally, Mr. Stern most recently served as chairman of the DRIF's National Board of Directors, is former chairman of the Northeast Regional Board and currently holds the title of immediate past president of the National Board.
Mr. Stern, who received a Bachelor of Arts degree from Dartmouth College and an MBA from Columbia Business School, is active in several other organizations. He serves as a member of the Board of Directors of the Birthright Israel Foundation, a member of the Board of Trustees of the American Jewish Committee, a Trustee of the Washington Institute for Near East Policy, and a member of the Investment Committee for Milton Academy in Milton, MA.